1. Home
  2. AVD vs GBIO Comparison

AVD vs GBIO Comparison

Compare AVD & GBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AVD
  • GBIO
  • Stock Information
  • Founded
  • AVD 1969
  • GBIO 2016
  • Country
  • AVD United States
  • GBIO United States
  • Employees
  • AVD N/A
  • GBIO 174
  • Industry
  • AVD Agricultural Chemicals
  • GBIO Biotechnology: Pharmaceutical Preparations
  • Sector
  • AVD Industrials
  • GBIO Health Care
  • Exchange
  • AVD Nasdaq
  • GBIO Nasdaq
  • Market Cap
  • AVD 171.3M
  • GBIO 145.5M
  • IPO Year
  • AVD N/A
  • GBIO 2020
  • Fundamental
  • Price
  • AVD $6.26
  • GBIO $2.18
  • Analyst Decision
  • AVD Strong Buy
  • GBIO Buy
  • Analyst Count
  • AVD 3
  • GBIO 4
  • Target Price
  • AVD $16.67
  • GBIO $7.50
  • AVG Volume (30 Days)
  • AVD 443.8K
  • GBIO 65.6K
  • Earning Date
  • AVD 08-08-2024
  • GBIO 08-07-2024
  • Dividend Yield
  • AVD 1.92%
  • GBIO N/A
  • EPS Growth
  • AVD N/A
  • GBIO N/A
  • EPS
  • AVD N/A
  • GBIO N/A
  • Revenue
  • AVD $585,049,000.00
  • GBIO $13,174,000.00
  • Revenue This Year
  • AVD N/A
  • GBIO $99.36
  • Revenue Next Year
  • AVD $4.69
  • GBIO N/A
  • P/E Ratio
  • AVD N/A
  • GBIO N/A
  • Revenue Growth
  • AVD 2.73
  • GBIO 1397.05
  • 52 Week Low
  • AVD $4.95
  • GBIO $0.86
  • 52 Week High
  • AVD $14.28
  • GBIO $4.83
  • Technical
  • Relative Strength Index (RSI)
  • AVD 45.76
  • GBIO 38.71
  • Support Level
  • AVD $5.61
  • GBIO $2.26
  • Resistance Level
  • AVD $5.87
  • GBIO $2.49
  • Average True Range (ATR)
  • AVD 0.25
  • GBIO 0.23
  • MACD
  • AVD 0.17
  • GBIO -0.03
  • Stochastic Oscillator
  • AVD 85.98
  • GBIO 1.85

About AVD American Vanguard Corporation ($0.10 Par Value)

American Vanguard Corp is a United States-based diversified specialty and agricultural products company. It manufactures and formulates chemicals for crops, turf and ornamental plants, and human and animal health protection. These chemicals include insecticides, fungicides, herbicides, molluscicides, growth regulators, and soil fumigants, which are marketed in liquid, powder, and granular forms.

About GBIO Generation Bio Co.

Generation Bio Co is a genetics medicine company that is focused on creating gene therapies to provide durable and redosable treatments for patients suffering from rare and untreated diseases. The company focuses on liver and retina-related diseases. It is developing two distinct and complementary platforms that It believes will enable highly differentiated therapeutic applications. Its first platform is a potent, highly selective ctLNP delivery system for nucleic acids, which is designed to avoid off-target clearance by the liver and spleen, enabling ctLNPs to persist in systemic circulation and allowing for highly selective and potent ligand-driven targeting to specific tissues and cell types. Its second platform is its novel iqDNA, which is an optimized variant of its ceDNA.

Share on Social Networks: